Peter Geschek
Peter Geschek
Stop FollowingPeter Geschek
ABOUT
Peter Geschek is a freelance writer, investor and the publisher of www.medfrontiers.com website. This is a site for medical innovation news and clinical trials news. Short, concise, important information about the latest is biotech and pharmaceuticals.
SNAPSHOT
- Description: Professional Blogger.
- Interests: ETFs
COMPANY
Currently, there is no company profile for Peter Geschek.
Book
Currently, there are no book details for Peter Geschek.
Latest Comments
more »
- hirokon:CORRECTIONYou are r... on Pfizer's Direct-To-Consumer Campaigns: A Model ...
- To: Tad RAs a matter of rul... on Sarepta Vs Glaxo In The Race To Treat Muscular ...
- To: themicrokidThe source o... on Sarepta Vs Glaxo In The Race To Treat Muscular ...
- Harrywins:This is a horribl... on Sarepta Vs Glaxo In The Race To Treat Muscular ...
- Steetre2:You are right, Mea... on Abbott Laboratories' Golden Goose: The Nutritio...
Latest comments on Peter's Articles
- Richard Parkinson on Ariad's Cancer Drug Iclusig Extends The Gleevec...
- rodolphe on Ariad's Cancer Drug Iclusig Extends The Gleevec...
- slimjim2005007 on Ariad's Cancer Drug Iclusig Extends The Gleevec...
- William Rilling on Bristol Myers Squibb And The New Wave Of Cancer...
- scdrecipe on After AbbVie's Humira: What Next?
Latest Articles on Healthcare
LATEST ARTICLES & INSTAPOSTS
more »
- Ariad's Cancer Drug Iclusig Extends The Gleevec Magic
- Bristol Myers Squibb And The New Wave Of Cancer Drugs
- Johnson & Johnson, Medtronic Frontrunners In Race To Develop Artificial Pancreas
- Pfizer's Direct-To-Consumer Campaigns: A Model For The Future?
- Billions In Renal Denervation: Medtronic, St. Jude

